This effect of tumor cells appears to be mediated by MDMX phosphorylation-dependent p53 downregulation in the host because blocking this MDMX phosphorylation prevented p53 decline and effectively mitigated the immunosuppressive TME, resulting in tumor growth delay. This evidence concerns the gene MDM4 and neoplasm.